Correlation Between Pharmacielo and Alterola Biotech

Can any of the company-specific risk be diversified away by investing in both Pharmacielo and Alterola Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmacielo and Alterola Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmacielo and Alterola Biotech, you can compare the effects of market volatilities on Pharmacielo and Alterola Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmacielo with a short position of Alterola Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmacielo and Alterola Biotech.

Diversification Opportunities for Pharmacielo and Alterola Biotech

0.32

Correlation Coefficient

Pharmacielo  Alterola Biotech

Weak diversification

The 3 months correlation between Pharmacielo and Alterola is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Pharmacielo and Alterola Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alterola Biotech and Pharmacielo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmacielo are associated (or correlated) with Alterola Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alterola Biotech has no effect on the direction of Pharmacielo i.e., Pharmacielo and Alterola Biotech go up and down completely randomly.

Pair Corralation between Pharmacielo and Alterola Biotech

Assuming the 90 days horizon Pharmacielo is expected to under-perform the Alterola Biotech. But the pink sheet apears to be less risky and, when comparing its historical volatility, Pharmacielo is 1.29 times less risky than Alterola Biotech. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Alterola Biotech is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  0.52  in Alterola Biotech on October 25, 2024 and sell it today you would lose (0.22) from holding Alterola Biotech or give up 42.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.16%
Values	Daily Returns

Pharmacielo  vs.  Alterola Biotech

Pharmacielo

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Pharmacielo has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Alterola Biotech

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Alterola Biotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Alterola Biotech may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Pharmacielo and Alterola Biotech

The main advantage of trading using opposite Pharmacielo and Alterola Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmacielo position performs unexpectedly, Alterola Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alterola Biotech will offset losses from the drop in Alterola Biotech's long position.

The idea behind Pharmacielo and Alterola Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.